March 27, 2026

FTC Launches Healthcare Task Force

Virginia Bell Flynn, Chad Fuller, Barbara Sicalides Troutman Pepper Locke + Follow Contact LinkedIn Facebook X Send Embed

On March 20, Federal Trade Commission (FTC) Chairman Andrew N. Ferguson issued a memorandum directing the creation of an internal Healthcare Task Force. The directive underscores that healthcare remains a top enforcement and policy priority for the FTC, reflecting the Administration’s focus on a “more competitive, innovative, affordable, and higher quality healthcare system.”

Background

Chairman Ferguson’s memorandum highlights the outsized role of healthcare in the U.S. economy, approximately 18% of GDP, and the disconnect between that level of spending and many patients’ ongoing difficulty accessing affordable care. The memo links those challenges to consolidation and other forms of allegedly anticompetitive conduct across healthcare markets, as well as to regulations that may weaken incentives to lower costs or improve quality. The Chairman emphasizes the particular impact on vulnerable populations, including rural communities, seniors, and veterans.

The memo also stresses the FTC’s “dual mandate” to police both unfair or deceptive practices and unfair methods of competition. Against that backdrop, the Healthcare Task Force is designed to break down silos within the agency and between it and other agencies, leverage the FTC’s wide-ranging healthcare experience, and ensure that enforcement and advocacy efforts are aligned across the agency.

Key Points

• Knowledge Sharing and Market Intelligence A central function of the Task Force will be to facilitate sharing of knowledge, resources, third‑party sources, market intelligence, case leads, and relationships with other agencies and stakeholders. This formal mechanism means that insights developed in one division (for example, in a consumer protection investigation) are more likely to inform other competition or policy initiatives.
• Focus on Emerging Issues and Horizon‑Scanning The Task Force will conduct ongoing “horizon‑scanning” exercises to identify emerging issues and new priority areas for enforcement and advocacy. This is likely to encompass digital health, telehealth, artificial intelligence (AI)‑enabled tools, health data platforms, and other technology‑driven business models in which the Office of Technology will play a meaningful role.
• Expanded Inter‑Agency Collaboration The memo explicitly calls for expanding participation to other government entities, including the Department of Health and Human Services and the Department of Justice, as well as other agency and law‑enforcement partners with relevant expertise. Companies may therefore see more coordinated activity across federal agencies on healthcare competition and consumer protection issues.
• Continued Scrutiny of Consolidation and Market Power By spotlighting recent merger challenges and references to “distorted” healthcare markets, the memo reinforces that consolidation will remain a core concern. Transactions involving hospitals, physician groups, payors, Pharmacy Benefit Managers (PBMs), device manufacturers, and other healthcare players — especially those affecting innovation or vulnerable patient populations — are likely to receive sustained scrutiny.
• PBMs, Pricing, and Transparency as Key Priorities The memorandum focuses on PBM practices, prescription drug pricing, and transparency. PBMs, plan sponsors, and manufacturers should expect continued attention to rebates, formulary design, steering, and related practices.
• Aggressive Consumer Protection in Health‑Related Marketing The memo recites a series of consumer protection actions in healthcare, including deceptive health plan marketing, misleading telehealth and weight‑loss programs, and products promoted with unsupported claims for serious conditions. Any entity marketing health‑related products or services should anticipate continued enforcement around claims substantiation, disclosures, endorsements, and steering. Our Take

The FTC’s Healthcare Task Force does not have the authority to promulgate new statutes or regulations, but it does formalize and strengthen an integrated investigative and enforcement structure. By bringing together the Bureau of Competition, the Bureau of Consumer Protection, the Bureau of Economics, the Office of Policy Planning, and the Office of Technology, the agency hopes to move more quickly and effectively on healthcare matters that straddle antitrust, consumer protection, and technology. The task force appears an effort to foster an increasingly prevalent enforcement strategy that combines consumer protection and antitrust theories to increase the likelihood of successful challenges.

Send Print Report

Latest Posts

• Troutman Pepper Locke Weekly Consumer Financial Services Newsletter – March 2026 #4
• FTC Launches Healthcare Task Force
• Delaware Court of Chancery Continues Recent Trend of Refusing to Blue-Pencil Overbroad Restrictive Covenants
• IEEPA Tariff Refunds May Come With an Unforeseen Cost — Exposure to Consumer Class Actions
• CCPA Cybersecurity Audits: Part 3 – Where CCPA Cybersecurity Audits Fit Within Existing Security Frameworks See more »

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

©
Troutman Pepper Locke

Written by:

Troutman Pepper Locke Contact + Follow Virginia Bell Flynn + Follow Chad Fuller + Follow Barbara Sicalides + Follow more less

PUBLISH YOUR CONTENT ON JD SUPRA

• ✔ Increased readership
• ✔ Actionable analytics
• ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Published In:

Antitrust Investigations + Follow Competition + Follow Digital Health + Follow Drug Pricing + Follow Federal Trade Commission (FTC) + Follow Healthcare + Follow Pharmacy Benefit Manager (PBM) + Follow Telehealth + Follow Unfair or Deceptive Trade Practices + Follow Administrative Agency + Follow Antitrust & Trade Regulation + Follow Consumer Protection + Follow Health + Follow Mergers & Acquisitions + Follow more less

Troutman Pepper Locke on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide